Clinical Trial Update: Transcranial Photobiomodulation for Executive Function in Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transcranial photobiomodulation to improve executive function in Bipolar Disorder has completed. Results were posted on 2025-08-28.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Paolo Cassano | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-08-28